Research and development in the pharmaceutical industry
Saved in:
Main Author: | Austin, David H |
---|---|
Corporate Author: | United States. Congressional Budget Office |
Format: | Online Book |
Language: | English |
Published: |
Washington, DC :
Congress of the United States, Congressional Budget Office,
[2006]
|
Series: | CBO study
|
Subjects: | |
Online Access: | http://purl.access.gpo.gov/GPO/LPS75169 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The law and ethics of the pharmaceutical industry /
by: Dukes, M. N. G. (Maurice Nelson Graham)
Published: (2006) -
Better pharmaceuticals for children : assessment and opportunities : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, first session on examining the impact of the pediatric exclusivity provision of the better pharmaceuticals for children act, which grants a pharmaceutical company an additional 6 months of market exclusivity for new or marketed drugs in exchange for conducting pediatric studies requested by the Food and Drug Administration, May 8, 2001.
Published: (2001) -
Safe harbor for preclinical use of patented inventions in drug research and development : Merck KGaA v. Integra Lifesciences I, Ltd. /
by: Yeh, Brian T.
Published: (2005) -
Competitive strategies in the pharmaceutical industry /
Published: (1996) -
Patent term extension and pharmaceutical innovation : hearing before the Subcommittee on Investigations and Oversight of the Committee on Science and Technology, U.S. House of Representatives, Ninety-seventh Congress, second session, February 4, 1982.
Published: (1983)